Study protocol for a randomized controlled trial: Qiliqiangxin in heart failUre: assESsment of reduction in morTality (QUEST)

BACKGROUND: Qiliqiangxin (QLQX) capsule is a Traditional Chinese Medicine (TCM) that has been approved in China for the treatment of chronic heart failure (CHF). Our previous study showed with a background of standard HF treatment, QLQX capsules further reduced the levels of NT-proBNP and the incide...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Wenming, Cheang, Iokfai, Liao, Shengen, Zhou, Yanli, Zhou, Fang, Xu, Dongjie, Jia, Zhenhua, Chang, Liping, Zhang, Haifeng, Li, Xinli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076750/
https://www.ncbi.nlm.nih.gov/pubmed/32024496
http://dx.doi.org/10.1186/s12906-020-2821-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076750/
https://www.ncbi.nlm.nih.gov/pubmed/32024496
http://dx.doi.org/10.1186/s12906-020-2821-0

Ejemplares similares